[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343471-105":59,"doc-detail-343471-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","inhibition-of-pnck-inflames-tumor-microenvironment-and-sensitizes-head-and-neck-squamous-cell-carcinoma-to-immune-checkpoint-inhibitors","Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors","","Background: The tumor microenvironment (TME) is tightly linked to the development of head and neck squamous cell carcinoma (HNSCC) and strongly shapes immunotherapy outcomes, while the role of PNCK in immune checkpoint inhibitor response remains unclear. Methods: Sequencing from patient cohorts and public datasets assessed PNCK expression, prognostic value, and predicted immune efficacy; in vitro and in vivo models evaluated PNCK function, including single-cell transcriptomics and proteomic mechanism studies. Results: Lower PNCK correlated with improved survival, stronger immune infiltration, and greater ICI responsiveness; PNCK promoted HNSCC growth and immune evasion. Conclusions: PNCK inhibition may enhance antitumor immunity, improve TME immunogenicity, and increase ICI efficacy in HNSCC patients.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inhibition-of-pnck-inflames-tumor-microenvironment-and-sensitizes-head-and-neck-squamous-cell-carcinoma-to-immune-checkpoint-inhibitors/343471/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inhibition-of-pnck-inflames-tumor-microenvironment-and-sensitizes-head-and-neck-squamous-cell-carcinoma-to-immune-checkpoint-inhibitors/343471.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the background rationale of the study regarding PNCK and HNSCC immunotherapy?","Question",{"text":112,"@type":113},"The study links the tumor microenvironment (TME) to HNSCC progression and immunotherapy efficacy, noting that PNCK’s role in immunotherapy response is not well understood.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were PNCK expression and its prognostic or immune effects evaluated?",{"text":117,"@type":113},"The researchers used sequencing data from their cohort and public databases to assess PNCK expression, prognostic significance, and immune efficacy prediction, supported by in vitro and in vivo experiments.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings on how PNCK affects immunotherapy response?",{"text":121,"@type":113},"Lower PNCK expression was associated with improved prognosis, increased immune cell infiltration, and enhanced responsiveness to immune checkpoint inhibitors, while PNCK promoted tumor progression and immune-related TME changes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343471,1790687817,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Open access Original research  \n Inhibition of PNCK inflames tumor  \nmicroenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors  \nQin Ding,1,2 Youliang Weng,1,2 Ying Li,1,2 Wanzun Lin,1,2 Xiaosan Lin,3 Tingting Lin,4 Hanxuan Yang,1,2 Wenqian Xu,1,2 Jianmin Wang,5,6 Hongmei Ying,7,8,9  \nSufang Qiu  1,2  \nTo cite: Ding Q, Weng Y, Li Y, et al. Inhibition of PNCK inflames tumor microenvironment and sensitizes head and necksquamous cell carcinoma to immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer 2024;12:e009893 . doi:10.1136/jitc-2024-009893  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2024-009893](jitc-2024-009893)) .  \nQD, YW and YL contributed equally.  \nAccepted 26 September 2024  \n© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Sufang Qiu;  \n[sufangqiu@fjmu.edu.cn](sufangqiu@fjmu.edu.cn)  \nDr Hongmei Ying; [yinghm@hotmail.com](yinghm@hotmail.com)  \nDr Jianmin Wang; [wangjm8605@163.com](wangjm8605@163.com)  \nABSTRACT  \nBackground The landscape of the tumor microenvironment (TME) is intricately linked to the development of head and neck squamous cell carcinoma (HNSCC) and significantly influences immunotherapy efficacy. Recent research has underscored the pivotal role of PNCK in cancer progression, yet its relationship with immunotherapy remains elusive.  \nMethods We leveraged sequencing data from our cohort and public databases to evaluate PNCK expression, prognostic significance, and immune efficacy prediction. In vitro and in vivo experiments explored the role of PNCK in HNSCC progression. Animal models assessed the therapeutic effects and survival benefits of PNCK knockdown combined with immune checkpoint inhibitors (ICIs) . Single-cell transcriptomics analyzed the impact of PNCK on the TME, and proteomic studies elucidated the mechanisms.  \nResults PNCK exerts multifaceted critical roles in the progression of HNSCC. Lower PNCK expression is associated with improved prognosis, enhanced immune cell infiltration, and increased responsiveness to ICIs. Conversely, PNCK promotes HNSCC cell migration, invasion, proliferation, colony formation, zebrafishangiogenesis, and tumor growth in mice. Moreover, targeting PNCK enhances sensitivity to ICIs and leads to significant alterations in the T-cell and B-cell ratios within the TME. These changes are attributed to the inhibition of nuclear transcription of PNCK-phosphorylated ZEB1, which restricts cytokine release and inflames the immune microenvironment to regulate the TME.  \nConclusions Inhibition of PNCK may be a potential strategy for treating HNSCC, as it may activate the immune response and improve the TME, thereby enhancing the efficacy of immunotherapy for HNSCC patients.  \nINTRODUCTION  \nHead and neck squamous cell carcinoma (HNSCC) constitutes a significant global health issue, ranking as the sixth most prevalent cancer globally.1 2 Recent clinical evidence has underscored the efficacy of  \n\n| WHAT IS ALREADY KNOWN ON THIS TOPIC |\n| --- |\n| ⇒ Clinical evidence demonstrates that immunotherapies are effective in managing cancer progression; however, resistance to immune checkpoint inhibitors (ICIs) is common, often resulting from genetic changes in tumor signaling. Previous reports have identified that PNCK is implicated in cancer progression and immune response modulation. Nevertheless, its role in head and neck squamous cell carcinoma (HNSCC), along with its association with the tumor microenvironment (TME) and immunotherapy, remains underexplored.\u003Cbr>WHAT THIS STUDY ADDS |\n| ⇒ Our study contributes significantly to the existing body of knowledge by providing novel insights into the multifaceted role of PNC","cbCaibjGWXVbeOkb","https://ap.wps.com/l/cbCaibjGWXVbeOkb","pdf",14520115,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Immune checkpoint inhibitor resistance and TME","[{\"question\":\"What is the background rationale of the study regarding PNCK and HNSCC immunotherapy?\",\"answer\":\"The study links the tumor microenvironment (TME) to HNSCC progression and immunotherapy efficacy, noting that PNCK’s role in immunotherapy response is not well understood.\"},{\"question\":\"How were PNCK expression and its prognostic or immune effects evaluated?\",\"answer\":\"The researchers used sequencing data from their cohort and public databases to assess PNCK expression, prognostic significance, and immune efficacy prediction, supported by in vitro and in vivo experiments.\"},{\"question\":\"What were the main findings on how PNCK affects immunotherapy response?\",\"answer\":\"Lower PNCK expression was associated with improved prognosis, increased immune cell infiltration, and enhanced responsiveness to immune checkpoint inhibitors, while PNCK promoted tumor progression and immune-related TME changes.\"}]","Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors | PDF",1790051260,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c822ae5a9a1ebb242c75327ce2a8d4b2.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a939bc50dbb7be183bc2745ebabc23d.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f114dc1b928fb0ea9fd32080475852f.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c21b16cab9c5fa2f888f61f451e05b1.webp",980,1306]